Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $2.21 Million - $2.52 Million
28,593 Added 37.68%
104,483 $8.67 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $381,398 - $547,556
-6,120 Reduced 7.46%
75,890 $6.52 Million
Q3 2022

Nov 18, 2022

BUY
$59.54 - $68.01 $133,548 - $152,546
2,243 Added 2.81%
82,010 $5.06 Million
Q2 2022

Aug 10, 2022

BUY
$57.72 - $65.01 $130,158 - $146,597
2,255 Added 2.91%
79,767 $4.93 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $476,565 - $597,188
8,228 Added 11.88%
77,512 $4.61 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $4.17 Million - $4.73 Million
64,253 Added 1277.14%
69,284 $5.03 Million
Q4 2021

Feb 10, 2022

BUY
$64.88 - $73.64 $326,411 - $370,482
5,031 New
5,031 $69.3 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Industrial Alliance Investment Management Inc. Portfolio

Follow Industrial Alliance Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.